- Home
- CEAD vs CYCN Comparison
CEAD vs CYCN Comparison
Compare CEAD & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- CYCN
- Stock Information
- Founded
- CEAD 2009
- CYCN 2018
- Country
- CEAD United States
- CYCN United States
- Employees
- CEAD N/A
- CYCN N/A
- Industry
- CEAD Industrial Machinery/Components
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- CYCN Health Care
- Exchange
- CEAD Nasdaq
- CYCN Nasdaq
- Market Cap
- CEAD 6.9M
- CYCN 7.5M
- IPO Year
- CEAD N/A
- CYCN N/A
- Fundamental
- Price
- CEAD $8.46
- CYCN $2.61
- Analyst Decision
- CEAD
- CYCN
- Analyst Count
- CEAD 0
- CYCN 0
- Target Price
- CEAD N/A
- CYCN N/A
- AVG Volume (30 Days)
- CEAD 22.9K
- CYCN 31.9K
- Earning Date
- CEAD 03-27-2025
- CYCN 03-04-2025
- Dividend Yield
- CEAD N/A
- CYCN N/A
- EPS Growth
- CEAD N/A
- CYCN N/A
- EPS
- CEAD N/A
- CYCN N/A
- Revenue
- CEAD $2,803,470.00
- CYCN $2,000,000.00
- Revenue This Year
- CEAD N/A
- CYCN N/A
- Revenue Next Year
- CEAD N/A
- CYCN N/A
- P/E Ratio
- CEAD N/A
- CYCN N/A
- Revenue Growth
- CEAD N/A
- CYCN N/A
- 52 Week Low
- CEAD $5.60
- CYCN $1.27
- 52 Week High
- CEAD $12.26
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- CEAD 49.33
- CYCN 47.14
- Support Level
- CEAD $7.90
- CYCN $2.44
- Resistance Level
- CEAD $9.45
- CYCN $2.85
- Average True Range (ATR)
- CEAD 0.86
- CYCN 0.20
- MACD
- CEAD 0.06
- CYCN 0.02
- Stochastic Oscillator
- CEAD 63.44
- CYCN 35.68
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.